Photochemical Tissue Passivation Treatment of Saphenous Vein Grafts in CABG

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

March 30, 2025

Conditions

Coronary Artery Disease

Interventions

DEVICE

DurVena Photochemical Tissue Passivation

Treatment of a saphenous vein graft with the DurVena Photochemical Tissue Passivation device.

Trial Locations (1)

Republican Scientific Center of Emergency Medical Care, Tashkent

All Listed Sponsors

lead

DurVena, Inc.

INDUSTRY